← Leaderboards
Christian Capitini
University Of Wisconsin-Madison
$4,273,809
Attributed
$6,560,968
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,041,936 · 6
By mechanism
P30$10,669,303 · 2
R01$5,657,673 · 3
K08$714,960 · 1
Top collaborators
- Peiman Hematti4 shared
- Krishanu Saha3 shared
- Melissa Caroline Skala3 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- David T Evans$32,138,335
- Aseem Z Ansari$9,477,080
- Rachel Kulow$8,109,307
- Peter M Carlson$101,908
- Brian William Pogue$26,364,458
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoResponseHigh RiskNovel TherapeuticsAllogenicMediatingLabelInfusion ProceduresMouse ModelTumorLeadProductionCytokineCellsSignal TransductionRadiationResearch PriorityImmunologicsInnovationHematopoietic Stem CellsTranslationsSolid NeoplasmPathway InteractionsCancer Cell
Grant awards (20)
UW Comprehensive Cancer Center Support$5,240,484
P30 · FY2025 · CA · contact PI
Label-free imaging of CAR T cell metabolism$647,057
R01 · FY2025 · CA
UW Comprehensive Cancer Center Support$5,240,484
P30 · FY2024 · CA · contact PI
Label-free imaging of CAR T cell metabolism$615,789
R01 · FY2024 · CA
Exosome educated monocytes for acute radiation syndrome$432,060
R01 · FY2024 · HL · contact PI
Label-free imaging of CAR T cell metabolism$662,022
R01 · FY2023 · CA
Exosome educated monocytes for acute radiation syndrome$525,256
R01 · FY2023 · HL · contact PI
Exosome educated monocytes for acute radiation syndrome$525,256
R01 · FY2022 · HL · contact PI
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma$347,078
R01 · FY2022 · CA · contact PI
Developmental Therapeutics Research Program$84,939
P30 · FY2022 · CA · contact PI
Exosome educated monocytes for acute radiation syndrome$525,256
R01 · FY2021 · HL · contact PI
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma$347,078
R01 · FY2021 · CA · contact PI
Developmental Therapeutics Research Program$103,396
P30 · FY2021 · CA · contact PI
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma$347,078
R01 · FY2020 · CA · contact PI
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma$336,665
R01 · FY2019 · CA · contact PI
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma$347,078
R01 · FY2018 · CA · contact PI
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy$178,740
K08 · FY2017 · CA · contact PI
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy$178,740
K08 · FY2016 · CA · contact PI
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy$178,740
K08 · FY2015 · CA · contact PI
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy$178,740
K08 · FY2014 · CA · contact PI